<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To analyze the epidermal growth factor receptor pathway substrate 8 (EPS8) expression status and role in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> given that EPS8 has a conserved actin barbed-end capping function that is required for proper maturation in intestinal cells </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We studied 8 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines and 58 colorectal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (19 <z:mpath ids='MPATH_270'>adenomas</z:mpath> and 39 <z:mp ids='MP_0002038'>carcinomas</z:mp>) </plain></SENT>
<SENT sid="2" pm="."><plain>We performed expression microarray analysis of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines followed by loss of heterozygosity (LOH) analysis and immunohistochemistry for EPS8 expression in <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Subsequently, we performed mutation analysis by direct sequencing and methylation analysis by <z:chebi fb="0" ids="17137">bisulfite</z:chebi> sequencing and methylation-specific polymerase chain reaction assays </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Expression microarray analysis of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines showed overexpression of EPS8 transcript in <z:hpo ids='HP_0000001'>all</z:hpo> lines but RKO </plain></SENT>
<SENT sid="5" pm="."><plain>Genome wide loss of heterozygosity (LOH) analysis of <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e>, showed considerable LOH at the EPS8 gene locus </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistochemically, EPS8 was constitutively expressed in <z:mpath ids='MPATH_458'>normal</z:mpath> colonic mucosa with a dot-like supranuclear localization with accentuation at the <z:chebi fb="2" ids="8069">luminal</z:chebi> surface supporting its proposed role in epithelial maturation </plain></SENT>
<SENT sid="7" pm="."><plain>Nineteen <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> (4 <z:mpath ids='MPATH_270'>adenoma</z:mpath>, 15 <z:mp ids='MP_0002038'>carcinoma</z:mp>) out of 51 (37%) showed strikingly <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> specific EPS8 protein loss </plain></SENT>
<SENT sid="8" pm="."><plain>Of the remaining <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, 5/51 (2 <z:mpath ids='MPATH_270'>adenoma</z:mpath>, and 3 <z:mp ids='MP_0002038'>carcinoma</z:mp>, 10%) showed marked overexpression, while 27/51 tumors (53%) showed retained expression </plain></SENT>
<SENT sid="9" pm="."><plain>Mutation analysis revealed a missense mutation (c.794C&gt;T, p.R265C) in exon 8 in RKO </plain></SENT>
<SENT sid="10" pm="."><plain>The EPS8 promoter was also methylated in RKO, but there was no significant methylation in other cell lines or <z:mp ids='MP_0002038'>carcinoma</z:mp> specimens </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: The loss of EPS8 expression in colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:mp ids='MP_0002038'>carcinomas</z:mp> suggests that down regulation of this gene contributes to the development of a subset of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>, a finding which could have applications in diagnosis and treatment </plain></SENT>
</text></document>